AI in medtech is booming. Track new devices here.

The Food and Drug Administration has authorized more medical devices that incorporate artificial intelligence. Keep track of the latest developments in this database.

By Elise Reuter , Jasmine Ye Han • Updated May 27, 2026

J&J subsidiary ordered to pay $147M for violating antitrust rules

A jury found that Biosense Webster withheld services to hospitals using reprocessed catheters.

By Elise Reuter • May 20, 2025

Explore the Trendline➔

Top 5 stories from MedTech Dive

From the effects of layoffs at the Food and Drug Administration and President Donald Trump’s tariff policies to the top medtech trends of 2026, here is a collection of top stories from MedTech Dive.

By MedTech Dive staff

EndoQuest, Virtuoso begin clinical trials for surgical robots

EndoQuest Robotics completed two procedures with its endoluminal system, while Virtuoso Surgical successfully performed bladder lesion excision in six patients.

By Susan Kelly • May 19, 2025

US signals reciprocal tariffs will return for some countries

The White House will alert countries of their specific rates in the next two to three weeks, President Donald Trump said Friday.

By Phil Neuffer • Updated May 20, 2025

Beyond sterility: The quiet engineering challenge behind every safe medical device

Inside the evolving science of sterilization compatibility and why your next packaging decision might improve patient outcomes.

May 19, 2025

House committees advance reconciliation text with big impacts on healthcare

Republicans in Energy and Commerce and Ways and Means have approved their portions of President Donald Trump’s “big, beautiful bill” after marathon markups. Here’s an extensive look at what the legislation means for healthcare.

By Rebecca Pifer Parduhn • May 16, 2025

Siemens Healthineers invests $150M in US, moves production from Mexico

News of the investment comes one week after Siemens Healthineers said tariffs will have a pretax impact of up to 300 million euros.

By Nick Paul Taylor • May 16, 2025

Intuitive CEO Gary Guthart to step down after 15 years

Dave Rosa, Intuitive Surgical’s president, takes over as chief executive, as the surgical robot maker accelerates the rollout of its latest da Vinci system.

By Susan Kelly • May 15, 2025

AdvaMed CEO Scott Whitaker pleads for tariff relief in Senate hearing

Whitaker repeated a call for “zero-for-zero” reciprocal tariffs between the U.S. and its trade partners in testimony before a Senate Finance Committee panel on critical supply chains.

By Susan Kelly • May 14, 2025

European Commission readies countermeasures to US tariffs

The commission is taking steps to target roughly $107 billion worth of imports if it can’t make a tariff deal with the U.S.

By Antone Gonsalves • May 14, 2025

Philips taps Nvidia to build AI model for MRI

Philips wants to create a foundation model for MRI to address challenges that are specific to the imaging technique.

By Nick Paul Taylor • May 14, 2025

Embecta restructures again, outlines tariff costs

The diabetes tech company announced a second restructuring after ending its insulin patch-pump program.

By Elise Reuter • May 13, 2025

Vicarious Surgical, UMass partner; SS Innovations targets de novo submission

Vicarious Surgical and SS Innovations marked progress toward bringing their robotic surgery systems to the U.S. market. The companies are among a new generation of robot developers planning to challenge Intuitive Surgical.

By Susan Kelly • May 13, 2025

Teal wins FDA approval for at-home cervical cancer screening device

The company plans to start shipping the device in June, starting in California and then expanding nationwide.

By Nick Paul Taylor • May 13, 2025

Roche plans $550M expansion of Indianapolis site to manufacture CGMs

Roche Diagnostics plans to produce glucose monitors at the site within three years and prepare for future generations of its sensors.

By Elise Reuter • May 12, 2025

US, China agree to reduce tariff rates for 90 days

By Wednesday, the two countries will charge 10% baseline duties during the period and remove certain retaliatory levies that pushed rates over 100%.

By Phil Neuffer • May 12, 2025

Solventum’s projected $100M tariff hit prevents earnings increase

CEO Bryan Hanson said tariffs have given “a higher sense of urgency” to the company’s existing efforts to regionalize its supply chains.

By Nick Paul Taylor • May 12, 2025

New Insulet CEO Ashley McEvoy sets priorities

The diabetes tech company raised its expectations for revenue and gross margins, despite the impact of tariffs.

By Elise Reuter • May 9, 2025

SEC ends probe of Illumina’s Grail acquisition

The DNA sequencing company also cut its 2025 earnings outlook to reflect the impact of tariffs on its business.

By Susan Kelly • May 9, 2025

FDA, aiming to speed scientific reviews, names chief AI officer

Commissioner Martin Makary also said the agency would roll out a generative AI system across its centers that will help FDA scientists spend less time on repetitive tasks.

By Susan Kelly • May 9, 2025

ADA’s Osagie Ebekozien on diabetes tech for Type 2, new CGM standards

Ebekozien, chief quality officer of the American Diabetes Association, said the nonprofit is seeing a shift with more devices authorized for Type 2 diabetes.

By Elise Reuter • May 9, 2025

Bausch + Lomb receives CE mark for Luxlife intraocular lens

The company plans to launch the lens, which supports vision at all distances, in Europe in the coming weeks.

By Nick Paul Taylor • May 9, 2025

US, UK reach deal on tariffs, market access

The deal includes a reduced tariff for some U.K. automobiles and is the first the Trump administration has secured after unveiling its reciprocal tariff plan in April.

By Phil Neuffer • May 8, 2025

Masimo says cyberattack has impacted its ability to fulfill orders

The maker of patient monitoring devices is working to bring the affected portions of its network back online and restore normal business operations.

By David Jones • May 8, 2025

Siemens Healthineers lowers earnings forecast on expected tariff hit

The company expects a tariff impact of up to 300 million euros, with the biggest hit from European goods going to the U.S.

By Nick Paul Taylor • May 8, 2025